Pharmaceutical Law & Industry Report® Index-Summary

NALFON

– Pain drug, FDA warns direct mailer on false or misleading advertising, 1050

NAMENDA

– Alzheimer's drug generic challenge, some firms dismissed (D. Del.), 1100

NANOTECHNOLOGY

– Collaboration announced by FDA, 291

NAPRELAN

– Anti-inflammatory drug infringement suit dismissed (S.D. Fla.), 284

NAROPIN

– Anesthetic, generic blocked (D.N.J.), 907; appealed, 1035

NATIONAL INSTITUTES OF HEALTH (NIH)

– Director confirmed, 948

NATRECOR

– Heart drug off-label use, feds intervene (N.D. Cal.), 226

NEO-SYNEPHRINE

– Nasal decongestant addiction, suit time-barred (N.D. Ill.), 177

NEUROTONIN

– Bulger suicide suit dropped on first day of testimony (D. Mass.), 914
– Epilepsy drug, causation evidence permitted in suicide suit over off-label use (D. Mass.), 556; class certification denied, 612
– Epilepsy drug, monopoly claim against maker may proceed (D.N.J.), 1026
– Monopoly claim against maker may proceed (D.N.J.), 1026
– Off-label uses, decertification challenged (Pa. Super. Ct.), 770
– Patient class decertified in off-label use suit (Pa. Ct. Com. Pl.), 258
– Widow of suicide victim sues, off-label use alleged (D. Minn.), 588

NEW HAMPSHIRE

– Adverse events reporting bill signed, 921
– Data mining, ban on prescription data sales upheld (U.S., rev sought), 363; other states await ruling, 544; (rev den), 763
– Privacy, shredding of health records, requirement considered, 184

NEW JERSEY

– Internet pharmacies regulation, Assembly approves, 321

NEW MEXICO

– Privacy, state considers requiring notification of E-health breaches, 184

NEW YORK

– Budget includes lower drug costs and bans industry gifts to MDs, 20; signed, 444
– Discounts, low-income drug card plan launched, 348
– Generic use down upstate, 209
– Pharmacies

– – Chains agree to free language services, 474
– – Language assistance required in N.Y.C., 1080

NEXIUM

– Heartburn drug, false advertising class action remanded (3rd Cir.), 587

NICODERM

– Canadian pricing hearing, challenge rejected, 1239

NIFEDIPINE

– Generic hypertension drug, direct purchasers antitrust class action certified (D.C. Cir.), 229

NIGERIA

– Trovan clinical trial claims

– – Kano settles with Pfizer, 913

– Trovan settlement, hearing planned on claim that Pfizer tried to circumvent victims' attorneys (Conn. Super. Ct.), 616

NORTH CAROLINA

– Medicaid fraud recoveries reported for 2008, 47
– Unused drugs and devices, donation bill signed, 950

NORVASC

– Blood pressure and angina drug patent invalidated by Canadian court, 839; reasons released, 1057

NORVIR

– Antitrust, maker cleared of monopoly charges (9th Cir.), 791; rehearing denied, 987; Analysis & Perspective, 1011
– Pricing

– – AIDS drug price settlement approved (N.D. Cal.), 942

NUVARING

– Contraceptive product liability, defendants barred from conducting ex parte interviews with treating MDs (E.D. Mo.), 367